Medtronic Ups Stake In China Cardiac Market With LifeTech Investment
This article was originally published in The Gray Sheet
Executive Summary
The $66 million deal gives Medtronic a significant stake in LifeTech, a Chinese developer of minimally invasive devices, including balloon catheters, delivery systems, occluders and stent graft systems.
You may also be interested in...
Seize China Opportunity Quickly, Morgan Stanley Analysts Urge
“Barriers to entry are higher than some investors appreciate, and fast followers may be on a path to permanent impairment,” industry analysts note in a recent market research report on the China opportunity for device manufacturers.
Medtronic Emphasizes International Growth Opportunities
Medtronic Inc. is betting on emerging markets and the “value” market to be its major growth drivers over the next few years.
Medtronic Emphasizes International Growth Opportunities
Medtronic is betting on emerging markets and the “value” market to be its major growth drivers over the next few years.